相关实验视频
Updated: Jan 16, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.8K
西利马林-阿尔法脂酸和与代谢功能障碍相关的脂肪性肝病:洞察力和方法考虑
Froylan David Martínez-Sánchez1, Sophia Eugenia Martínez-Vázquez1, Ricardo Gutiérrez-Monterrubio1
1Department of Gastroenterology and Hepatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan 14080, CDMX, Mexico.
World journal of hepatology
|September 30, 2025
概括
这项研究探讨了Silybum marianum和α-酸 (SM-ALA) 配合地中海饮食的配方,用于代谢功能障碍相关的脂肪性肝病. 虽然注意到一些代谢改善,但研究的局限性需要进一步严格的临床试验.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 营养科学 营养科学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题.
- 目前的管理通常涉及生活方式干预,但需要新的治疗策略.
研究的目的:
- 评估Silybum marianum和α-酸 (SM-ALA) 的专有配方与地中海饮食相结合在MASLD患者中的疗效.
- 评估这种联合干预对代谢参数的影响.
主要方法:
- 一项涉及MASLD患者的临床试验.
- 干预组与地中海饮食一起接受了SM-ALA配方.
- 对比组的细节和具体的结果措施在摘要中没有完全详细说明.
主要成果:
- 在接受SM-ALA配方和地中海饮食的患者中观察到初步的代谢益处.
- 该研究没有包括一个SM-ALA-only组进行直接比较.
- 缺少组织学数据和可靠的统计分析.
结论:
- 结合SM-ALA和地中海饮食显示出管理MASLD代谢并发症的潜力.
- 包括小样本大小和缺乏对照组在内的限制限制了最终的结论.
- 建议根据药物试验标准进行进一步的研究.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K

